Position in RDY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$789,934
+$78,780 QoQ
Shares Held
57,035
+12.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $1,131,904,343 across 44 Drug Manufacturers - Specialty & Generic names. RDY ranks #36 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,649,955 | $195,041,180 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3,315,973 | $171,402,644 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
1,247,447 | $164,338,667 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
4,595,535 | $140,071,906 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
153,372 | $90,946,528 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,893,845 | $57,042,611 | |
| 7 | PRGO |
PERRIGO Co plc
|
4,279,731 | $45,964,310 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
592,013 | $45,525,799 |
All Filings in RDY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $789,934 | 57,035 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $711,154 | 50,652 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,770,908 | 555,859 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,980,794 | 1,528,995 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $57,297,360 | 4,344,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $44,806,209 | 2,837,632 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,691,263 | 159,739 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $25,333,327 | 332,502 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,112,300 | 206,030 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,360,915 | 19,559 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $24,180,726 | 361,608 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $20,696,167 | 327,938 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,830,632 | 119,983 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,105,328 | 21,359 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $805,826 | 15,396 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,949,185 | 53,244 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $36,803,757 | 660,394 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,728,934 | 255,755 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $13,364,187 | 205,161 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,677,190 | 50,023 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $19,575,245 | 318,867 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $19,925,911 | 279,505 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $551,819 | 7,933 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $375,552 | 9,312 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||